Across TCGA pan-cancer cohorts, MIR208B RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of MIR208B’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where MIR208B RNA is repressed in tumor relative to normal tissue. In most cancer types MIR208B is over-expressed in tumor, although a few such as PRAD show the opposite, repressed pattern.

PRAD are the cancer types where MIR208B tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR208B RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PRAD	All	All	−0.085	.024	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: MIR208B RNA expression & survival · all MIR208B data types